🇺🇸 FDA
Pipeline program

ssCART-19 cells combined with CD19+ feeding T cells (FTCs) infusion

SZCART01

Phase 2 mab active

Quick answer

ssCART-19 cells combined with CD19+ feeding T cells (FTCs) infusion for Acute Lymphoblastic Leukemia, Adult B-Cell is a Phase 2 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Acute Lymphoblastic Leukemia, Adult B-Cell
Phase
Phase 2
Modality
mab
Status
active

Clinical trials